Predicting transformation in follicular lymphoma

References

• Rosenberg S A. Follicular lymphoma revisited. J Clin Oncol 2008; 26: 515–516
   PubMed Web of Science ®Google Scholar
• Montoto S, Davies A J, Matthews J, et al. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol 2007; 25: 1–8
   PubMed Web of Science ®Google Scholar
• Al-Tourah A J, Gill K K, Chhanabhai M, et al. Population-based analysis of incidence and outcome of transformed non-Hodgkin lymphoma. J Clin Oncol 2008; 26: 5165–5169
   PubMed Web of Science ®Google Scholar
• Horning S J, Rosenberg S A. The natual history of initially untreated low-grade non-Hodgkin lymphomas. N Engl J Med 1984; 311: 1471–1475
   PubMed Web of Science ®Google Scholar
• Jaffe E, Harris N L, Stein H, et al. WHO classification of tumours of haematological and lymphoid tissues. IARC Press, Lyon 2001
   Google Scholar
• Swerdlow S H, Campo E, Harris N L, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon 2008
   Google Scholar
• Glas A M, Knoops L, Delahaye L, et al. ASH Annual Meeting Abstract. 2006; 823
   Google Scholar
• de Jong D, Voetdijk B HM, Beverstock G C, et al. Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma presenting as a composite lymphoma. N Engl J Med 1988; 318: 1373
   PubMed Web of Science ®Google Scholar
• Yano T, Jaffe E S, Longo D L, et al. MYC rearrangements in histologically progressed follicular lymphomas. Blood 1992; 80: 758–767
   PubMed Web of Science ®Google Scholar
• Haralambieva E, Boerma E J, van Imhoff G W, et al. Clinical, immunophenotypic and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol 2005; 29: 1086–1094
   PubMed Web of Science ®Google Scholar
• McClure R F, Remstein E D, Macon W R, et al. Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior. Am J Surg Pathol 2005; 29: 1652–1660
   PubMed Web of Science ®Google Scholar
• Le Gouill S, Talmant P, Touzeau C, et al. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 2007; 92: 1335–1342
   PubMed Web of Science ®Google Scholar
• Kanungo A, Medeiros L J, Abruzzo L V, et al. Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis. Mod Pathol 2006; 19: 25–33
   PubMed Web of Science ®Google Scholar
• Kramer M HH, Raghoebier S, Beverstock G C, et al. De novo acute B-cell leukemia with translocation t(14;18): an entity with a poor prognosis. Leukemia 1999; 14: 1960–1966
   Google Scholar
• Horsman D E, Connors J M, Pantzar T, et al. Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chrom Cancer 2001; 30: 375–382
   PubMed Web of Science ®Google Scholar
• Höglund M, Sehn L, Connors J M, et al. Identification of cytogenetic subgroups and karyotype pathways of clonal evolution in follicular lymphomas. Genes Chrom Cancer 2004; 39: 195–204
   PubMed Web of Science ®Google Scholar
• d.Amore F, Chan E, Iqbal J, et al. Clonal evolution in t(14;18) positive follicular lymphoma, evidence for multiple common pathways and frequent parallel clonal evolution. Clin Can Res 2008; 14: 7180–7187
   PubMed Web of Science ®Google Scholar
• Elenitoba-Johnson K SJ, Gascoyne R D, Lim M S, et al. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histological progression in follicle center lymphoma. Blood 1998; 91: 4677–4685
   PubMed Web of Science ®Google Scholar
• Lossos I S, Levy R. Higher grade transformation of follicle center lymphoma is associated with somatic mutation of the 5′ non-coding regulatory region of the bcl-6 gene. Blood 2000; 96: 635–639
   PubMed Web of Science ®Google Scholar
• Lo Cocco F, Gaidano G, Louie D C, et al. P53 mutations are associated with histological transformation of follicular lymphoma. Blood 1993; 82: 2289–2295
   PubMed Web of Science ®Google Scholar
• Davies A J, Lee A M, Taylor C, et al. A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma. Leukemia 2005; 19: 1459–1465
   PubMed Web of Science ®Google Scholar
• Martinez-Climent J A, Alizadeh A A, Segraves R, et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood 2003; 101: 3109–3117
   PubMed Web of Science ®Google Scholar
• Glas A M, Kersten M J, Delahaye L JMJ, et al. Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood 2005; 105: 301–307
   PubMed Web of Science ®Google Scholar
• De Vos S, Hofman W K, Grogan T M, et al. Gene expression profile of serial samples of transformed B-cell lymphoma. Lab Invest 2003; 83: 271–285
   PubMed Web of Science ®Google Scholar
• LeBrun D, Baetz T, Foster C, et al. Predicting outcome in follicular lymphoma using interactive gene pairs. Clin Cancer Res 2008; 14: 478–487
   PubMed Web of Science ®Google Scholar
• Lossos I S, Alizadeh A A, Diehn M, et al. Transformation of follicular lymphoma to diffuse large cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci USA 2002; 99: 8886–8891
   PubMed Web of Science ®Google Scholar
• Davies A J, Rosenwald A, Wright G W, et al. Transformation of follicular lymphoma to diffuse large cell lymphoma proceeds by distinct oncogenic mechanisms. Br J Haematol 2006; 136: 286–293
   Web of Science ®Google Scholar
• Maesako Y, Uchiyama T, Ohno H. Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt lymphoma and de novo diffuse large B-cell lymphoma. Cancer Sci 2003; 94: 774–781
   PubMed Web of Science ®Google Scholar
• Carlotti E, Wrench D, Matthews J, et al. Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone. Blood 2009; 113: 3553–3557
   PubMed Web of Science ®Google Scholar
• Ruminy P, Jardin F, Picquenot F, et al. Sμ mutation patterns suggest different progression pathways in follicular lymphoma: early direct or late from FL progenitor cells. Blood 2008; 112: 1951–1959
   PubMed Web of Science ®Google Scholar
• O'Shea D, Riain C O, Gupta M, et al. Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. Blood 2009; 113: 2298–2301
   PubMed Web of Science ®Google Scholar
• Glas A M, Knoops L, Delahaye L, et al. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol 2007; 25: 390–398
   PubMed Web of Science ®Google Scholar
• Farinha P, Masoudi H, Skinnider B F, et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood 2005; 106: 2169–2174
   PubMed Web of Science ®Google Scholar
• Lee A M, Clear A J, Calaminici M, et al. Number of CD4+ cells and location of forkhead box protein P3-poitive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. J Clin Oncol 2006; s24: 5052–5059
   Web of Science ®Google Scholar
• Alvaro T, Lejeune M, Salvado M-T, et al. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. J Clin Oncol 2006; 24: 5350–5357
   PubMed Web of Science ®Google Scholar
• Carreras J, Lopez-Guillermo A, Fox B C, et al. High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 2006; 108: 2957–2964
   PubMed Web of Science ®Google Scholar
• Canioni D, Salles G, Mounier N, et al. High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. J Clin Oncol 2008; 26: 440–446
   PubMed Web of Science ®Google Scholar
• De Jong D. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol 2005; 23: 6358–6363
   PubMed Web of Science ®Google Scholar
• Cerhan J R, Ansell S M, Fredericksen Z S, et al. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 2007; 110: 4455–4463
   PubMed Web of Science ®Google Scholar
• Rothman N, Skibola C F, Wang S S, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the Inter Lymph Consortium. Lancet Oncol 2005; 7: 27–38
   Web of Science ®Google Scholar
• Cerhan J R, Wang S, Mauer M J, et al. Prognostic significance of host gene polymorphisms in follicular lymphoma. Blood 2007; 109: 5439–5446
   PubMed Web of Science ®Google Scholar
• Ekstrom K, Lindgren C M, Hjargrim H, et al. Variation in DNA repair genes ERCC1, XRCC1 and XRCC3 and risk of follicular lymphoma. Cancer Epidemiol Biomarkers Prev 2006; 15: 258–265
   PubMed Web of Science ®Google Scholar